← Eichor
Study identifier: NCT07136207 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Development and Validation of Delirium Recognition Using Computer Vision in Neuro-critical Patients

Condition: Delirium · Artificial Intelligence (AI)  ·  Sponsor: Beijing Tiantan Hospital

PhaseN/A
Planned participants1000
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

This research project employs machine learning algorithms integrated with computer vision, image processing, and pattern recognition technologies to perform digital analysis of facial expression behaviors in neurocritical care patients with delirium. By constructing multidimensional high-level features of delirium, the investigators have established a classification model based on behavioral. The primary objective of this study is to address the critical challenge of achieving precise and efficient delirium diagnosis in neurologically critically ill patients through automated facial expression behavior recognition.

This description comes directly from the study's public registry record.

Talk to the study team

Huang Huawei, Doctoral degree  ·  +8613599058877  ·  huanghw0403@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Beijing Tiantan HospitalBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07136207